IP Library Granted Patent US 7,582,103
Granted Patent B2
US 7,582,103 · App. 11/607,237 · Granted Sep 1, 2009

Tissue opening occluder

Assignee: ev3 Endovascular, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,582,103
App. No.
11/607,237
Granted
Sep 1, 2009
Kind
B2
Abstract

A tissue opening occluder comprising first and second occluder portions, each occluder portion including a frame structure and an attachment structure to attach one portion to the other portion. The frames may be utilized to constrain the tissue between the two portions enough to restrict the significant passage of blood therethrough. The frame portions may be covered by a fabric suspended from a perimeter thereof. The occluder portions are conjoined at least one point on each portion.

Claims (6)

1. A method of occluding an opening between overlapping atrial septa of a patent foramen ovale (PFO), the overlapping atrial septa forming a PFO tunnel, comprising:

deploying a tissue opening occluder comprising a support structure within the PFO tunnel between the overlapping atrial septa; and

engaging an anchor element carried by the support structure with heart tissue from within the PFO tunnel once the support structure is positioned in the PFO tunnel, the anchor element piercing heart tissue from within the PFO tunnel to secure the occluder in position within the PFO tunnel.

2. The method of claim 1 , wherein the anchor element pierces and passes through heart tissue once the support structure is positioned in the PFO tunnel.

3. The method of claim 1 , wherein the tissue opening occluder further comprises a fabric supported by the support structure, and the fabric promotes tissue growth to permanently anchor the occluder in intimate contact with a tissue wall.

4. The method of claim 1 , wherein the support structure is received and retained exclusively within the PFO tunnel.

Assignments (3)
MERGER Recorded Feb 5, 2010
From: MICROVENA CORPORATION
To: EV3 INC.
Reel/Frame 023916/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2010
From: THILL, GARY A.; YOUNG, MICHELLE M.; OMAN, JANA F.; BARRATT, PAUL R.
To: MICROVENA CORPORATION
Reel/Frame 023917/0555 →
CHANGE OF NAME Recorded Feb 5, 2010
From: EV3 INC.
To: EV3 ENDOVASCULAR, INC.
Reel/Frame 023917/0886 →
Continuity (5)
Division 1020979700 · Jul 30, 2002
Provisional Application 6030933700 · Aug 1, 2001
Provisional Application 6030937600 · Aug 1, 2001
Provisional Application 6030941800 · Aug 1, 2001
Related Publication 20070112382A1 · May 17, 2007